Click below to share this pageTweet
Published: May 17, 2016 11:40:00 AM
Published: May 15, 2016 9:56:00 AM
Published: Apr 21, 2016 10:20:47 AM
- Grand Challenges 2021: The Next Five Years
- Grand Challenges UCL 2034 Grants
- UCL Researchers: Why contribute to The Conversation?
- Grand Challenges Student Fund: up to £750 available for student led projects – More
The Alzheimer Enigma in an Ageing World
Thursday 24 October (6pm-7.30pm) followed by a drinks reception
A lecture by Professor Margaret Lock , Marjorie Bronfman Professor in Social Studies of Medicine, Emerita, Dept. of Social Studies of Medicine, McGill University
Alzheimer’s disease is increasingly described today as an epidemic, with estimates of 115 million cases worldwide by 2050. Less visible are the ongoing epistemological arguments in the medical world about the observed entanglements of AD type dementia with “normal” aging, and the repeated efforts to delineate what exactly constitutes this elusive yet devastating condition. In early 2011 official statements appeared in relevant medical journals about a so-called paradigm shift involving a move towards a preventative approach to AD in which the detection of biomarkers indicative of prodromal Alzheimer’s disease is central. In this talk I will discuss the significance of risk predictions associated with such biomarkers, and the irresolvable uncertainties such information raises for involved individuals and families.
Welcome: Professor Andrew Steptoe, Director, Institute of Epidemiology and Health Care, UCL
Introduction and chair: Dr Sahra Gibbon, UCL Anthropology
Page last modified on 12 apr 16 12:51